94 results on '"Schaenman, Joanna"'
Search Results
2. Corrigendum to “Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study” [eBioMedicine 83 (2022) 104208]
3. Physical Frailty Predicts Outcomes in Patients Undergoing Evaluation for Kidney Transplantation
4. Donor call simulation: A novel medical education tool to evaluate trainees’ clinical decision‐making in transplant infectious disease
5. Domestically Acquired NDM-1–Producing Pseudomonas aeruginosa, Southern California, USA, 2023
6. Pretransplant Screening for Infection Exposure: Approach to the Patients with Epidemiologic and Geographic Risk Factors
7. Risk factors for infection in patients with a failed kidney allograft on immunosuppressive medications
8. Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic Investigation
9. Like watching a soccer game through a keyhole: Cytomegalovirus cell‐mediated immunity incompletely reveals risk for clinically significant cytomegalovirus reactivation in cord blood transplant recipients
10. Living kidney donors with HIV: experience and outcomes from a case series by the HOPE in Action Consortium
11. Pretransplant Screening for Infection Exposure: Approach to the Patients with Epidemiologic and Geographic Risk Factors
12. Vascular and Non-HLA autoantibody profiles in hospitalized patients with COVID-19
13. Longitudinal analysis of the LA-SPARTA cohort of high-risk individuals after SARS-CoV-2 infection and vaccination
14. Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants
15. Cowpox to COVID: History of vaccination in the immunocompromised host
16. Frailty and Age-Associated Assessments Associated with Chronic Kidney Disease and Transplantation Outcomes
17. West Nile Virus in Immunocompromised Hosts
18. Prevention and Treatment of Polyomavirus-Associated Diseases
19. Enterovirus Infection in Immunocompromised Hosts
20. Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor–Intolerant Patients
21. Predictors of COVID-19 outcomes: Interplay of frailty, comorbidity, and age in COVID-19 prognosis
22. Corrigendum to “T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients” [Hum. Immunol. 83(4) (2022) 273–280]
23. Sarcopenia Predicts Outcomes After Lung Transplantation in Older Lung Transplant Candidates
24. 240.3: Detection of CMV Mediated Sub-Clinical Rejection by Urine Biomarkers
25. 401.6: Circulating Plasma Proteomics Analysis of CMV Infection in Kidney Transplantation.
26. Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction
27. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study
28. Editorial: Immune Aging: Implications for Transplantation
29. Impact of solid organ transplant status on outcomes of hospitalized patients with COVID‐19 infection
30. T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients
31. Mycoplasma hominis infections in solid organ transplant recipients: Clinical characteristics, treatment outcomes, and comparison of phenotypic and genotypic susceptibility profiles
32. Enteral feeding tube administration with therapeutic drug monitoring of crushed posaconazole tablets and opened isavuconazonium sulfate capsules
33. Benefits of both physical assessment and electronic health record review to assess frailty prior to heart transplant
34. NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant
35. Predictive value of chart‐based frailty evaluation for lung transplant candidates
36. Frailty and aging-associated syndromes in lung transplant candidates and recipients
37. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection
38. Leukocyte transcriptome indicators of development of infection in kidney transplant recipients
39. Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis
40. Spectrum of Coronavirus Disease 2019 Outcomes in Kidney Transplant Recipients: A Single-Center Experience
41. 1109. Valgancyclovir Dosing for Cytomegalovirus Prophylaxis in Heart Transplant Recipients
42. Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients
43. Heart transplantation in the early phase of the COVID‐19 pandemic: A single‐center case series
44. DNA Methylation Age Is More Closely Associated With Infection Risk Than Chronological Age in Kidney Transplant Recipients
45. The aging transplant population and immunobiology: any therapeutic implication?
46. Coinfections of Two Strains of NDM-1- and OXA-232-Coproducing Klebsiella pneumoniae in a Kidney Transplant Patient
47. Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support
48. The Frailty Risk Score predicts length of stay and need for rehospitalization after kidney transplantation in a retrospective cohort: a pilot study
49. Cutaneous Fungal Masses From Prior Environmental Injury Following Kidney Transplant: A Case Report
50. WATERBORNE PARASITES | Entamoeba
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.